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Abstract
Background
Patients undergoing conventional hemodialysis (C-HD) present a greater immuno-inflam-
matory state probably related to uremia, sympathetic nervous system (SNS) activation and
/or membrane bioincompatibility, which could improve with a technique-switching to online
hemodiafiltration (OL-HD). The antigen-independent pathway activation of this modified
immunologic state turns dendritic cells (DC) into an accurate cell model to study these
patients. The aim of this study is to further evaluate the immune-inflammatory state of
patients in C-HD assessed by DC maturation.
Methods
31 patients were submitted to C-HD and after 4 months switched to the OL-HD technique.
Monocytes-derived DCs from HD patients were cultured in the presence of IL-4/GM-CSF.
DC-maturation was evaluated by assessing the maturation phenotype by flow cytometry
(FACs). DCs-functional capacity to elicit T-cell alloresponse was studied by mixed leuco-
cyte reaction. Cytokine release was assessed by FACs and SNS was evaluated measuring
renalase levels by ELISA.
Results
An up-regulation of maturation markers was observed in C-HD DCs which induced two fold
more T cells proliferation than OL-HD DCs. Also, C-HD-mDCs presented with over-produc-
tion of pro-inflammatory cytokines (IL-6, IL-1β, IL-8, IL-10 and TNF-α) compared with OL-
HD-mDC (P<005). Results were correlated with clinical data. When SNS was evaluated,
hypotension events and blood pressure were significantly lower and renalase levels were
significantly higher after conversion to OL-HD. Diabetes mellitus type 2 patients also found
beneficial reduction of mDC when converted to OL-HD compared to non-diabetics.
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Conclusions
OL-HD could interfere with immuno-inflammatory state in HD patients with an improvement
of renalase levels as potential key mediators in the mechanistic pathway of down-regulation
of DC maturation.
Introduction
Inclusion in the dialysis program involves an annual mortality of individuals between 13 and
20%, with an annual cardiovascularmortality of 9%. Part of the high risk of mortality and car-
diovascular disease in dialysis patients has been attributed to baseline inflammatory status [1–
4]. In addition, there is an increase in basal concentrations of pro and anti-systemic inflamma-
tory cytokines in patients with renal replacement therapy [5] or by bioincompatibility with the
dialyzer membrane, endotoxemia, infections and clinical events [6–10]. An activation of SNS
has also been described [11, 12].
Accurate basic research studies and randomized controlled studies are needed to analyze
the pathophysiology of the inflammation. Dendritic cells (DC) are potent antigen presenting
cells, essential to trigger and to maintain immune responses (IR), able to link innate IR to adap-
tive IR. Our group previously demonstrated that DC can be activated by a non-antigen depen-
dent stimulus, such as hypoxia [13–15], and thus, susceptible to be modulated by uremia and
stress (SNS). Vitamin D also has an inhibitory effect on the adaptive immune system by regu-
lating the function of DCs [16–18]. Thus, DCmaturation could be a tool to clarify the triangle
inflammation-SNS-uremia. In fact, chronic inflammation based on an increase of proinflam-
matory cytokines in patients on HD could trigger the function and activation of DCs [19].
Emerging evidence from other studies [20] suggests that the lack of removal of medium-sized
molecules by C-HDmay contribute to an increased inflammatory state supported by the data
analysis of the CONTRAST study [21]. C-HD offers excellent clearance of small molecules, how-
ever, the morbidity and mortality in the dialysis population reaches inappropriately high percent-
ages in relation to the general population. In fact, OL-HD combines both diffusion and
convection, using high fluxmembranes and replacing the high convective volumes generated by
ultrapure dialysis fluid, allowing the removal of medium size molecules by diffusion [22, 23]. This
greater removal of uremic toxins could have an impact in reduction of inflammation and of SNS-
activation, which could be related to DCmodulation. In fact, it has been reported that patients
treated with OL-HD showed lowered percentage of peripheral bloodmyeloid DC [24, 25].
This study confers an original approach by monitoring the inflammatory state of the
patients in OL-HD versus C-HD assessed by the functional study of DCsmaturation and the
antigen independent stimuli such as SNS which could provide better understanding of the
potential benefits of OL-HD. For this purpose, in this study we evaluate for the first time the
role of DCs in the inflammatory state which is inherent to patients with ESRD undergoing
replacement therapies for the first time, comparing both techniques: C-HD and OL-HD and
also assessing the impact of metabolic and SNS activation on DCmodulation.
Methods
Patients
A total of 31 stable HD patients were included betweenMay 2013 and May 2014. All patients
had been treated in BellvitgeHospital and the satellite dialysis center of Vilanova, for at least 6
months before inclusion and remained on the same technique of HD during the whole study.
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Twenty nine of the 31 patients finished the study. Two patients dropped out during the follow-
up (one caused by influenza AH1N1 and one due to for pulmonary infection). Patients with
active infection and neoplasic disease were excluded. Informed consent was obtained from all
patients following the ethics committee of the hospital. Six patients undergoing kidney disease
in pre-dialysis state were included as control. The follow-up was divided in two periods: Period
1 based on 4 month for high flux hemodialysis (C-HD) and Period 2 based on 4 months for
online hemodiafiltration (OL-HD).
At inclusion, all patients had been on C-HD for at least 6 months and using polysulfone
membranes (1.8 m2, HF80; Fresenius Medical Care, Bad Homburg, Germany). OL-HD was
performedwith ultrapure bicarbonate-buffered dialysate three times a week. Kt/V was deter-
mined at midweek of the last week. Analysis of the dialysis system always revealed absence of
bacteria (<0.1 colony-forming units/ml) or bacteriological contaminant products (endotoxin
levels<0.03 endotoxin units/ml) during the whole period of the study. The dialysis characteris-
tics were similar in the two modalities, except for a higher convective transport in the OL-HD
than in C-HD. In OL-HD, the mean volume infusedwas recorded and was found to be>20 L
per session. The composition of dialysate was the same in both OL-HD as in C-HD and also in
the of reinfusate in OL-HD (sodium 138–140mmol/L, potassium 1.5–2.0 mmol/L, calcium
1.25–1.75 mmol/L, magnesium 0.5 mmol/L, chloride 106–109 mmol/L, bicarbonate 34–37
mmol/L, acetate 3–4 mmol/L, and glucose 1.0 g/L).
Patients underwent C-HD with dialyzer surface area of 1.7 to 2.1 m2 membranes and sur-
face area was maintained when patients were converted to OL-HD. Dialysis efficiencywas esti-
mated using eKt/V ratio. All patients had a native arteriovenous fistula and two patients
showed an arteriovenous graft. Basal data were collected to record age, gender, weight, height,
underlying renal disease, dialysis vintage, history of transplantation, diabetes, comorbid condi-
tions, current medication, blood pressure and hypotension. Hypotensive events were defined
as a decrease in systolic blood pressure of20 mmHg or a decrease in MAP of 10 mmHg
associated with symptoms. None of the patients were on anti-inflammatory or immunosup-
pressive drugs during the 3 months before inclusion and for the whole period of the study.
Nine patients were diabetic. The therapeutic regimen, which consisted of erythropoietin
(EPO), calcium-containing phosphate binders, antihypertensive drugs, and intravenous iron,
was changed according to the clinical needs. Patients received EPO from the beginning of the
study. EPO dosage was adjusted to maintain the hemoglobin target of 11.5 to 12 g/dl. All rou-
tine laboratorymeasurements were done using certificate assay methods. All patients received
paricalcitol iv therapy during the study follow up, attending to medical needs.
Blood samples were obtained from all patients just before the first (long interval) dialysis
session of the following period to study the effect after 4 months of OL-HD.
Ethics statement
Human cells were obtained in accordance with protocols approved by the Ethics Committee of
the Hospital Bellvitge of Barcelona (Barcelona, Spain) and in accordance with the principles of
the Declaration of Helsinki. Written informed consent was obtained from the participants.
Isolation and culture of cells
Whole peripheral blood samples obtained fromHD patients and healthy subjects were col-
lected in tubes that contained K3EDTA (9mL) immediately before dialysis treatment and pro-
cessed within 1h of collection. Peripheral bloodmononuclear cells (PBMCs) were isolated by
density gradient centrifugation (Ficoll-PaqueTM PLUS; GE Healthcare, Uppsala, Sweden).
10x106 cells were incubated for 2h at 37°C in 5% CO2 in 25cm2 flask plates. After washing, the
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adherent monocytes were cultured in complete medium that contained X-VIVOTM supple-
mented with 2% Human Serum (Sigma-Aldrich;Madrid, Spain) in the presence of IL-4 (500U/
ml; Sigma) and granulocytemonocytes colony-stimulating factor (GM-CSF 1000U/mL; R&D
Systems, Minneapolis, MN, US) for a total of 6 days at 37°C in a humidified atmosphere of 5%
CO2, obtaining 90% DC purity at day 6. Analysis of different cellular subpopulations during
differentiation and maturation of dendritic cells (DCs) and the gating strategy for DC popula-
tion was described and validated in our previous studies [15].
Dendritic cell phenotype analysis by flow cytometry
After 6 days of culture, different cell surfacemarkers were analyzed by flow cytometry to study
the maturation process of DC on C-HD and OL-HD patients. This cytometric analysis was
made by FACS CANTOTMII and the data was analyzed using FACS DIVA software (Becton-
Dickinson, San Diego, CA, US). In order to examine the DCmaturation, the markers used
were: CD80 (Clone BB1), CD83 (Clone HB15e) and HLA-DR (Clone G46-6) conjugated with
fluorescein isothiocyanate (FITC) and CD40 (Clone 5C3), CD86 (Clone 2331 FUN-1), and
CD54 (Clone HA58) conjugated with allophycocyanin (APC). The cytometric protocol and
the combination of the antibodies used in our experiments were describedby our group in pre-
vious studies [15, 26]. To assess the differentiation of monocytes along the culture, CD14
(CloneM5E2) FITC antibody was used. All the antibodies were mouse monoclonal from Bec-
ton-Dickinson Pharmingen.
Allogeneic mixed leucocyte reaction. T-Cell proliferation
We then next tested weather DCs have an impact on T-cell proliferation. For this purpose, we
performed a CFSE assay in order to analyze the effector function of DCs.We isolated DCs
from C-HD/OL-HD and mixed them with frozen PBMCs from healthy volunteers by perform-
ing MLR [27, 28]. The allogenic PBMCs were labelled with CFSE (carboxyfluoresceindiacetate
succinimidyl ester;Molecular Probes, Madrid, Spain) and exposed to mature DCs fromHD
patients. Allogeneic CFSE-labelled PBMCs (2×105) were co-cultured in 96-well round-bottom
plates in the presence of DCs (2×104) collected at the end of the 6-day culture at a 1:10 DCs-to-
T-cell ratio. The mixt culture was incubated in RPMI medium (GE Healthcare Life Sciences
HyClone Laboratories, Logan, UT, US) supplemented with 10% FBS (Cultek, Madrid, Spain),
100 U ml-1 of penicillin, 100 μgml-1 streptomycin and 2mM L-Glutamine at 37° and 5% CO2
conditions. After 5 days of culture, the cells were labelled with CD3 (Clone HIT3a) APC (Bec-
ton-Dickinson Pharmingen) to analyze T-cell proliferation by flow cytometry by FACS CAN-
TOTMII and analyzed by FACS DIVA software.
Quantification of cytokine production by DCs using cytometric bead
array
After MLR, serum and supernatants fromHD patients after MLR were collected. Cytokine lev-
els of Interleukin-1β, -6, -8, -10, -12p70 and TNF-α were measured quantitatively by the cyto-
metric bead array technique (CBA Human Inflammatory Cytokines Kit, BectonDickinson).
The levels were measured according to the manufacturer’s instructions. Flow cytometry analy-
sis was performed using FACS CANTO and FACS DIVA software.
Quantification of Renalase
SNS was analyzed by quantification of renalase. The enzyme-linked immunosorbent assay
(ELISA) Kit (Uscn Life Science Inc. China) using a monoclonal antibody specific to renalase,
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was performed in cells supernatant and serumof HD patients (C-HD and OL-HD) in order to
estimate the renalase concentration. The enabled protocol frommanufacturer’s instructions
was used.
Statistical Analyses
Clinical and biological parameters were describedusing mean and standard deviation for con-
tinuous variables and frequencies for categorical variables. Differences between study group
means were tested by paired t-test. A subgroup analysis was conducted on diabeticmellitus
patients. Differences between diabetic and non-diabetic patients were tested by t-test.
Spearman correlation between renalase and number of hypotension events was performed.
A linear regression model was estimated to test the association between renalase and systolic
blood pressure and between convective volume in HD-OL and DCmaturation. Also Pearson
correlation was performed between renalase values and systolic blood pressure. P<0.05 was
considered statistically significant. All statistical analyses were conducted using SPSS v17.
Limitations of the study
This is a longitudinal study design with the methodological limitations of this approach. Thus,
the possibility that the effect could be related to longer dialysis treatment period cannot be
ruled out.
Results
1. Analysis of DC populations under C-HD and OL-HD patients
At day 0, the analysis of different cellular subpopulations during the differentiation and matu-
ration of DCs showed a high percentage of monocytes (CD14+) and the presence of several
lymphocyte subtypes. During differentiation, the CD14+ population expressed DCsmarkers
such as (HLA-DR+ and CD11c+) and the lymphocyte percentage diminished after removing
the medium and replacing it with fresh culture medium. DC population was gathered in two
subpopulations, depending on the degree of maturation according to the forward-/side-scatter
profile and specific phenotypic markers established in our previous study [13, 15]. Cells
changed their morphology, acquiring a stellate form, characteristic of the mature DC (mDC)
shifting to the upper window depending on the dialysis technique.
C-HD patients at baseline express higher percentage of mDCs compared to uremic patients
pre-dialysis (50.06 ± 4.41 versus 28 ± 5.1; p = 0.001) S1 Table. After 4 months under OL-HD,
these same patients showed a marked decrease in the percentage of mature DCs compared
with C-HD status (31.91 ± 3.15; vs 50.06 ± 4.41; p = 0.001) (Fig 1A and S1 Table). Also, C-HD
induced higher DCmaturation, this was statistically significant compared to OL-HD analyzed
as intensity of different maturation markers (CD40, CD80, CD83, CD86 and CD54) (Fig 1B
and 1C). C-HD patients at baseline expressed a high percentage of mDCs compared to uremic
patients pre-dialysis (50.06 ± 4.41 versus 28 ± 5.1; p = 0.001). After 4 months under OL-HD,
these same patients showed a marked decrease in the percentage of mature DCs compared
with C-HD status (31.91 ± 3.15; vs 50.06 ± 4.41; p = 0.001) (Fig 1A and S1 Table)., In addition,
C-HD induced higher DCmaturation, which was statistically significant compared to OL-HD
analyzed as intensity of different maturation markers (CD40, CD80, CD83, CD86 and CD54)
(Fig 1B and 1C). Maturation-DC degree was also analyzed in association with different convec-
tive volumes under OL-HD, no correlation was found betweenDCsmaturation and the differ-
ent convective volumes (Fig 1D).
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2. T- cell proliferation in C-HD and OL-HD patients
To address the functional impact of C-HD vs OL-HD on DCs, we then assessed the effects of
DCs on lymphocyte proliferation by MLR.Matured DCs from C-HD (C-HD-mDC) signifi-
cantly induced T-cell proliferation compared to matured DCs fromOL-HD patients (2A).
(OL-HD-mDC) (71.44±7.7 vs 29.46±7.75; p = 0.03). OL-HDmatured DCs achieved similar T
cell proliferation and uremic control (29.10±9.29) (Fig 2B and S1 Table).
3. Cytokine release in serum and in supernatant of PBMCs after MLR
Cytokine release of IL-6 and TNF-α from patients on C-HD did not present statistically signifi-
cant differences compared to those on OL-HD (Fig 3A and S1 Table). On the other hand, cyto-
kine release in the mixed culture with mDCs and lymphocytes showed a different pattern
depending on the HD technique. PBMCs, mostly lymphocytes, stimulated by C-HD-mDCs
presented statistically significant over-production of IL-1β, IL-6, IL-10 and TNF-α, related
mainly to a T helper type 1 (Th1) response, compared with control (Fig 3B and S1 Table). In
Fig 1. Dendritic cell maturation. A. Modulation of dendritic cell maturation in HD and uremic patients. DCs were obtained from HD and uremic patients
and were cultured for 6 days. Expression of cell surface markers was evaluated by flow cytometry and the results were expressed as the percentage of
matured DC. B. In the histogram, monocytes are represented in yellow, the immature DC in orange, the matured DC in green and the negative control in
grey. MFI and expression of each marker are presented as mean ± SD. C. or Expression of cell surface markers evaluation by the mean fluorescence
intensity (MFI) of different maturation markers as CD40, CD80, CD83, CD86, CD54 and HLA-DR in C-HD and OL-HD groups. D. Correlation between
DCs maturation and the different convective volumes (D).
doi:10.1371/journal.pone.0164969.g001
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contrast, IL-8 was over-expressed in PBMCs exposed to OL-HD-mDCs, suggesting a switch to
a Th2 response (Fig 3B and S1 Table).
4. Impact of OL/HD in diabetic and non diabetic patients
Diabetic C-HD patients showed higher percentage of dendritic cell maturation compared to
non-diabetic patients C-HD (66.85±3.92 vs 48.13±4.62 respectively;p = 0.03). Interestingly,
Fig 2. OL-HD reduces T-cell proliferation induction by DC in the MLR. A. Lymphocytes were stained with
CFSE and exposed to mature DCs (Uremic control vs C-HD vs OL-HD) during 6 days of culture. B. Cell
proliferation was determined by flow cytometry after labelling with CD3 antibody.
doi:10.1371/journal.pone.0164969.g002
Online Haemodiafiltration Improves Inflammatory State in Dialysis Patients
PLOS ONE | DOI:10.1371/journal.pone.0164969 October 26, 2016 7 / 16
diabeticOL-HD patients showed a tendency towards lower dendritic cell maturation values
but the switch C-HD to OL-HD reduced the difference in DCmaturation between diabetics
and non-diabetics respectively (44.16±7.54 vs 31.31±4.17; p = 0.164).
Diabetic patients under C-HD showed higher percentage of lymphocyte proliferation on
CFSE after MLR, compared to diabetic patients under OL-HD (78.85±1.2 vs 12.7±2.6 respec-
tively; p = 0.04); the switch of C-HD to OL-HD in non diabetic patients showed a slight reduc-
tion in lymphocyte proliferation by CFSE, not achieving statistical differences.
5. Biochemical and clinical parameters
Biochemical data were assessed by conventional venoclysis for parameters related to ESRD
under replacement therapy before HD sessions. All relevant biochemical and clinical data are
Fig 3. Cytokine release. A. Different pattern of cytokine release was obtained in OL-HD compared to C-HD. IL-6 and TNFα
levels from serum. B. 1β, IL-6, IL-8, IL-10, IL-12p70 and TNFα secretion protein levels from cell supernatant after MLR were
measured by cytometric bead array. The results are expressed in pg/ml ± SD.
doi:10.1371/journal.pone.0164969.g003
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summarized in Tables 1 and 2; and S1 Table. Interestingly, there was a better management of
systolic and diastolic blood pressure and less episodes of severe hypotension in OL-HD patients
compared with C-HD (systolic TA. 130.33±3.5 vs 148.12±5.1; p<0.001; diastolic TA. 65.70±2.8
vs 72.87±1.9; p = 0.04) and severe hypotension episodes (0.12±0.6 vs 1.62±0.22; p = 0.001).
6. OL-HD benefit in renalase release
Renalase in C-HD patients serum levels were assessed by ELISA in serumof C-HD patients
and in the same patients after four months of conversion to OL-HD. Interestingly; renalase lev-
els were significantly higher for patients undergoing OL-HD (Fig 4 and S1 Table). In fact, there
was a correlation of renalase levels with clinical parameters related to SNS. Higher renalase val-
ues correlated with lower severe hypotension events (-0,410 (Rho value) p = 0.0033) and better
systolic blood pressure control (0,327 (Rho value) p = 0.0587). Indeed, renalase levels would be
160 fold higher for every reduction in systolic blood pressure of 10mmHg (-16,08 (beta value)
(Fig 5).
Discussion
Inflammation in patients with ESRD undergoing HD is an increasing concern for physicians
and has been related to increase the rates of morbidity and mortality [29–31]. Interestingly,
patients with ESRD in C-HD have frequent infections and a suboptimal response to vaccines;
this is probably related to an immune inflammatory disorder associated either with uremia and
/ or nutritional status [32]. In this sense, OL-HD has been shown to improve cardio-protection
and the immunologic system and reduces infection and mortality compared with C-HD [33].
A recent study showed that OL-HD compared with C-HD reduced the risk of mortality in
ESRD patients [34].
As our group previously revealed, DCs are the most potent APCs in the initiation of an
immune-inflammatory response, either after antigen or non-antigen-dependent stimuli as our
Table 1. Baseline characteristics.
Parameter
Age 72±15
Gender (M/F) 17/14
Native arteriovenous fistula 30
Arteriovenous graft 1
ESRD ethiololgy
• Diabetes 10
• Polycystic disease 3
• Autoimmune disease 0
• Nephrotoxicity 1
• Urologic 4
• Vascular 5
• Not known 8
Dialysis vintage (months) 46.54
Kidney transplant 1
Exitus 2
Number of patients 31
Table 1 shows demographic parameters of patients throughout the study. Twenty-nine of the 31 patients
finished the study.
doi:10.1371/journal.pone.0164969.t001
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group previously revealed [15]. An aberrant DC function in HD patients has also been recently
suggested as a cause of impaired immune response [19] due to a strong alteration in DCs gen-
eration and maturation in ESRD [35]. Considering the capacity and the central role of DC, the
present study extends the characterization of monocytes to DCs to evaluate for the first time
the role of DCS in inflammation on C-HD. For this purpose, we evaluated the change in the
morphology and phenotype of DCs in C-HD patients. As we have previously described,mDCs
changed their morphology acquiring a characteristic stellate form based on a non-antigen stim-
ulation of DCs as we have previously described.Thus, we made an attempt to evaluate whether
uremic milieu and hemodialysis technique per se could trigger adaptative immune response
throughmodulation of DCs. For this, maturation of monocyte-derivedDCs from patients
undergoing C-HDwas evaluated and compared to monocyte-derivedDCs of the same patients
after four months under OL-HD therapy. Interestingly, percentage of mDCwas lower in
OL-HD patients, which decodes in a lower inflammatory state under this technique. According
to our results, several studies have shown the positive effect of OL-HD on cardiovascular sur-
vival and co-morbidity of patients [33, 34, 36–39].
To evaluate DC function, an allo-mixed lymphocyte reaction was performed to analyze the
capacity of DCs to stimulate proliferation of naive T cells. Functional impact of mDC showed a
higher stimulatory capacity in allogeneic T-cell proliferation for patients exposed to C-HD
than those under OL-HD. Patients with OL-HD achieved the same T cell proliferation than
control-uremic patients although these reached higher values compared to healthy volunteers.
In fact, it has been reported that aberrant mDCs in C-HD patients have have a higher T cell
proliferation stimulatory capacity than that in control healthy volunteers [19]. Choi et al, [19]
postulated that there is a possibility that chronic inflammationmight affect DC function,
resulting in abnormal allostimulatory capacity. Lymphocytes stimulated by mature DCs release
Table 2. Biochemical and clinical characteristics.
Parameter (Mean ± SD) C-HD OL-HD P
Weight (Kg) 70.1 ± 13.6 70.4 ± 16.4 0.9392
Ferritina (μg/L) 615.35±87.04 586.53±96.83 0.15
% DC maturation 50.06 ±4.41 31.91 ± 3.15 0.001
CFSE 71.44±7.70 29.46±7.75 0.03
iPTH (Pmol/L) 28.76±33.65 22.00±18.16 0.25
Calcidiol (nmol/L) 34.54±2.01 46.65±10.20 0.20
Fosfate (mmol/L) 1.26±0.45 1.30±0.79 0.79
Albumin (g/L) 38.7±2.5 39.08±3.3 0.397
nPCR 1.08±0.09 1.10±0.09 0.201
PCR 15.057±16.18 12.802±15.8 0.48
Blood Pressure
• Systolic 148.12±5.1 130.33±3.5 0.001
• Diastolic 72.87±1.9 65.70±2.8 0.04
• Hypotension events 1.62±0.22 0.12±0.6 0.001
Renalase (ng/ml) 103.12±6.43 162,83±10.39 0.0001
Hemoglobin (g/L) 11.58±2.43 12.67±1.65 0.37
Leukocytes (x109 cells/L) 7158.00±370.45 6986.8±345.51 0.019
Lymphocytes (x109 cells/L) 1364.61±97.11 1335.15±103.89 0.5
eKt/V ratio 1.58±0.33 1.62±0.35 0.12
Table 2 shows demographic and biochemical parameters of patients throughout the study. The follow-up was divided in two periods: Period 1 based on 4
months of high flux hemodialysis (C-HD) and Period 2 based on 4 months of online hemodiafiltration (OL-HD).
doi:10.1371/journal.pone.0164969.t002
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a broad array of cytokines exerting a wide influence on the immune system. Depending on the
HD technique, our results showed a different pattern in the cytokine release by lymphocytes
after the mixed culture with mDCs. Therefore, lymphocytes stimulated by mDCs from C-HD
patients showed a higher secretion of cytokines related to Th1 response compared with those
stimulated by mDCs from OL-HD patients who mainly expressed a cytokine Th2 profile.
These results support other studies which reveal that dysregulated cytokine network -anti-
inflammatory (IL-10) and proinflammatory (IL-6 and TNF-α) cytokines- play an important
role in the wasting syndrome of uremic milieu [35, 40].
Our novel results show that the greater removal of uremic toxins by OL-HD has an impact
in reducing of inflammation due to DCmodulation. Another source of the non-antigen depen-
dent pathway activation of DCs could be stress of patients on C-HD due to an increase of sym-
pathetic nerve activity [12]. In this sense, renalase is a protein that oxidizes circulating
catecholamines regulating heart rate and blood pressure which translate to sympathetic SNS
activity. In this study, patients showed low renalase levels when they were submitted to C-HD
and after four months of OL-HD their serum levels of renalase increased. These results corrob-
orate that less inflammation leads to increased renalase levels, achieving values similar to those
Fig 4. Renalase release is higher in patients following OL-HD than in those following CD-HD. C-HD and OL-HD patients’ serum
renalase levels were measured by ELISA. The results are expressed in ng/ml ± SD.
doi:10.1371/journal.pone.0164969.g004
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in healthy volunteers. This effect was robust, and probably the lower inflammatory profile
could bring to an epinephrine via α-adrenoceptor/NF-κβ lower stimulation [11, 12]. Also, in
this study, patients showed better control of Blood Pressure and less hypotensive events were
noted, showing a better control of SNS [22, 33]. Those findings positively correlated with
higher levels of renalase levels.
In the inflammatory field, several studies have demonstrated the immunosuppressive effects
of vitamin D3 in the functions of DCs [41–48]. In this sense calcidiol levels showed a tendency to
be higher in OL-HD patients compared to those on C-HD although values were not statistically
different. It has been described that calcidiol or vitamin D suppresses the maturation of DCs.
Recently, the MPO (Membrane Permeability Outcome) study highlighted that survival was
significantly increased in high-flux vs low-fluxmembranes in high-risk patients with serum
albumin4 g/dL and diabetic patients [36]. In this sense, the impact of OL-HD in diabetic and
non-diabetic patients was evaluated. Dendritic cell maturation in diabetic C-HDwas higher
than in non-diabetic, this corroborates a basal inflammatory state in these patients. In fact, DC
maturation in diabetic C-HDwas corrected after the change of technique to OL-HD, achieving
similar values to non-diabeticOL-HD, suggesting a correction in basal inflammation state in
diabeticHD patients. These results are physiopathologically supported by the findings reported
in MPO [36], ESHOL [33] and other studies [34]. Furthermore, these results were in concor-
dance with T cell proliferation. Diabetic patients under C-HD showed higher percentage of
lymphocyte proliferation on CFSE compared to diabetic patients under OL-HD. These differ-
ences were not so appreciated as much in non-diabetic patients.
Fig 5. Correlation of serum renalase levels with hypotension events and systolic blood pressure control.
doi:10.1371/journal.pone.0164969.g005
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In summary, the novelty of this study reveals functional improvement in inflammatory
state in patients with a technique-switching to OL-HD, beingmore notable in diabetic patients.
The originality of these results arises from an OL-HD-modulation of the immuno-inflamma-
tory state mediated by DCmaturation-down-regulation and control of the SNS improving
renalase levels in HD patients.
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